The U.S. Centers for Disease Control and Prevention (CDC) has identified a total of 121 cases of Measles covering 17 states and the District of Columbia. Because of the high rate of transmission, they expect this number to continue to grow. Do you know best practices for preventing transmission?
New Prevantics® Device Swab from PDI Receives FDA 510k Market Authorization.
The ONLY 3.15% Chlorhexidine Gluconate/ 70% Isopropyl Alcohol solution that has received market authorization by the U.S. Food and Drug Administration (FDA) for disinfecting needleless access sites prior to use.
REQUEST MORE INFORMATION
Infections associated with Carbapenem-resistant Enterobacteriaceae (CRE) organisms are on the rise among patients in medical facilities. Due to the high mortality rate associated with the infections caused by these organisms, your facility should be prepared.
PDI can help. Learn more